Marion Caseris
Overview
Explore the profile of Marion Caseris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Charlier C, Anselem O, Caseris M, Lachatre M, Tazi A, Driessen M, et al.
Infect Dis Now
. 2024 Feb;
54(4):104857.
PMID: 38311003
No abstract available.
12.
Cohen R, Dortet L, Caseris M, Raymond J, Lorrot M, Toubiana J
Infect Dis Now
. 2023 Oct;
53(8S):104794.
PMID: 37802213
Resistance of Gram-negative bacteria to the most widely used antibiotics, particularly β-lactams, is now considered as major public health problem. The main resistance mechanisms to β-lactams in Enterobacterales are the...
13.
Assad Z, Valtuille Z, Rybak A, Kaguelidou F, Lazzati A, Varon E, et al.
Chest
. 2023 Aug;
165(1):150-160.
PMID: 37544426
Background: Acute chest syndrome (ACS) is a life-threatening complication of sickle cell disease (SCD). Although respiratory pathogens are frequently detected in children with ACS, their respective role in triggering the...
14.
Pasqualini C, Cohen L, Le Roux E, Caseris M, Faye A
Front Pediatr
. 2023 Jul;
11:1145191.
PMID: 37404556
Introduction: We assessed the risk of tuberculosis (TB), the management and the outcomes of 0-5-year-old children after TB contact investigations in a low-burden setting. Method: All 0-5-year-old children who attended...
15.
Mallart E, Francoise U, Driessen M, Blanche S, Lortholary O, Lefort A, et al.
J Allergy Clin Immunol
. 2023 May;
152(3):760-770.
PMID: 37210041
Background: Primary immunodeficiencies (PID) are a heterogeneous group of rare inborn immunity defects. As management has greatly improved, morbidity and mortality are reduced in this population, while our knowledge on...
16.
Cordesse A, Ecochard-Dugelay E, Melki I, Caseris M, Belarbi N, Hugot J, et al.
JPGN Rep
. 2023 May;
1(2):e007.
PMID: 37206602
Tumor necrosis factor-α (TNF-α) inhibitors have resulted in significant progress in the treatment of chronic inflammatory diseases. However, these therapies can lead to paradoxical immune-mediated inflammatory diseases with unknown physiopathology....
17.
Lassoued Y, Assad Z, Ouldali N, Caseris M, Mariani P, Birgy A, et al.
Open Forum Infect Dis
. 2023 May;
10(5):ofad188.
PMID: 37180594
In a 15-year pediatric time-series analysis, we showed a rise of invasive Group A streptococcal (iGAS) infections since October 2022, mainly involving pleural empyema, simultaneously to a respiratory virus outbreak....
18.
Yang J, Michel M, Cogo H, Malorey D, Poey N, Caseris M, et al.
J Pediatr
. 2023 Mar;
259:113395.
PMID: 37001636
Objective: To assess the association between deprivation and the incidence and clinical severity of tuberculosis (TB) in children. Study Design: Children ≤18 years old who were admitted for TB between...
19.
See P, Bonacorsi S, Toumazi A, Doit C, Naudin J, Chomton M, et al.
Arch Pediatr
. 2023 Feb;
30(3):153-157.
PMID: 36822930
Background: Staphylococcus aureus (SA) is one of the main pathogens responsible for healthcare-associated infection (HCAI) in pediatrics. The aim of this study was to describe the prevalence of SA-HCAI among...
20.
Pinto Cardoso G, Lagree-Chastan M, Caseris M, Gaudelus J, Haas H, Leroy J, et al.
Front Pediatr
. 2022 Dec;
10:1000657.
PMID: 36507149
Background: In Europe, meningococcal (Men) vaccines are available against 5 of the 6 serogroups responsible of nearly all cases of invasive meningococcal disease (IMD). Meningococcal vaccination has been introduced in...